Sicart Associates LLC Guardant Health, Inc. Transaction History

Sicart Associates LLC

$274 Million
Q2 2025

A detailed history of Sicart Associates LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Sicart Associates LLC holds 165,455 shares of GH stock, worth $7.82 Million. This represents 3.15% of its overall portfolio holdings.

Number of Shares

165,455

Previous 137,593 20.25%

Holding current value

$7.82 Million

Previous $5.86 Million 46.9%

% of portfolio

3.15%

Previous 2.1%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 18, 2025	BUY	$37.05 - $52.04 $1.03 Million - $1.45 Million	27,862 Added 20.25%	165,455 $8.61 Million
Q1 2025 Apr 24, 2025	SELL	$31.77 - $49.94 $87,049 - $136,835	-2,740 Reduced 1.95%	137,593 $5.86 Million
Q4 2024 Jan 14, 2025	SELL	$20.2 - $38.11 $120,594 - $227,516	-5,970 Reduced 4.08%	140,333 $4.29 Million
Q3 2024 Oct 25, 2024	BUY	$22.3 - $36.29 $7,136 - $11,612	320 Added 0.22%	146,303 $3.35 Million
Q2 2024 Aug 02, 2024	SELL	$16.07 - $31.84 $9,786 - $19,390	-609 Reduced 0.42%	145,983 $4.22 Million
Q1 2024 May 02, 2024	BUY	$17.13 - $26.91 $918,836 - $1.44 Million	53,639 Added 57.71%	146,592 $3.02 Million
Q4 2023 Jan 19, 2024	SELL	$21.58 - $29.5 $64,135 - $87,674	-2,972 Reduced 3.1%	92,953 $2.51 Million
Q3 2023 Oct 25, 2023	BUY	$25.8 - $39.97 $76,239 - $118,111	2,955 Added 3.18%	95,925 $2.84 Million
Q2 2023 Jul 28, 2023	BUY	$20.94 - $38.01 $63,867 - $115,930	3,050 Added 3.39%	92,970 $3.33 Million
Q1 2023 May 09, 2023	SELL	$22.92 - $33.76 $184,964 - $272,443	-8,070 Reduced 8.24%	89,920 $2.11 Million
Q4 2022 Jan 27, 2023	SELL	$25.44 - $59.78 $978,651 - $2.3 Million	-38,469 Reduced 28.19%	97,990 $0
Q3 2022 Nov 01, 2022	SELL	$43.66 - $61.0 $62,433 - $87,230	-1,430 Reduced 1.04%	136,459 $7.35 Million
Q2 2022 Aug 05, 2022	BUY	$28.82 - $77.35 $121,706 - $326,649	4,223 Added 3.16%	137,889 $5.56 Million
Q1 2022 May 06, 2022	BUY	$48.25 - $100.49 $4.43 Million - $9.22 Million	91,783 Added 219.14%	133,666 $8.85 Million
Q4 2021 Jan 31, 2022	BUY	$88.71 - $120.43 $3,637 - $4,937	41 Added 0.1%	41,883 $4.2 Million
Q3 2021 Oct 22, 2021	BUY	$98.77 - $132.17 $130,573 - $174,728	1,322 Added 3.26%	41,842 $5.23 Million
Q2 2021 Jul 23, 2021	BUY	$109.77 - $165.68 $4.45 Million - $6.71 Million	40,520 New	40,520 $5.03 Million

Others Institutions Holding GH

# of Institutions

393

Shares Held

121M

Call Options Held

1.43M

Put Options Held

2.37M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.83B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sicart Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sicart Associates LLC with notifications on news.

Account

Sicart Associates LLC Guardant Health, Inc. Transaction History